Clinical trial
Stimulant and Polysubstance Use, Inflammation, and Sex Effects on Myocardial Disease in HIV (SPISE)
NCT07461350 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Stimulant and Polysubstance Use, Inflammation, and Sex Effects on Myocardial Disease in HIV (SPISE)
- Lead sponsor
- University of California, San Francisco
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- August 5, 2026
- Completion date
- March 31, 2030
- Enrollment
- 400 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
hiv (human immunodeficiency virus)